Analytical Data
-
基因名
TNFSF15
- Application
-
别名
TNFSF15；TL1；VEGI；Tumor necrosis factor ligand superfamily member 15
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O95150
-
表达区间
72-251aa
-
氨基酸序列
LKGQEFAPSHQQVYAPLRADGDKPRAHLTVVRQTPTQHFKNQFPALHWEHELGLAFTKNRMNYTNKFLLIPESGDYFIYSQVTFRGMTSECSEIRQAGRPNKPDSITVVITKVTDSYPEPTQLLMGTKSVCEVGSNWFQPIYLGAMFSLQEGDKLMVNVSDISLVDYTKEDKTFFGAFLL
-
分子量
25.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TNFSF15, also known as tumor necrosis factor ligand superfamily member 15, is a cytokine that plays a crucial role in immune regulation and inflammation. It is primarily expressed in various tissues, including the intestines, and is involved in the development and maintenance of the gut-associated lymphoid tissue. Research into TNFSF15 has gained significant attention due to its potential implications in various diseases, particularly inflammatory bowel disease (IBD) and cancer. Dysregulation of TNFSF15 has been linked to increased inflammatory responses and alterations in immune cell function, highlighting its dual role in promoting both immune protection and pathogenic inflammation. The recombinant form of TNFSF15 has been developed for various applications, including the study of immune responses and therapeutic interventions. By understanding its interactions with receptors and downstream signaling pathways, researchers aim to elucidate the mechanisms by which TNFSF15 modulates immune responses and contributes to disease processes. This research not only enhances our knowledge of TNFSF15's biological functions but also opens up potential avenues for developing novel therapeutic strategies targeting inflammatory and autoimmune disorders.
